|
|
|
Is Dr Wheatgrass supporting medical research?
| Question |
| Is Dr Wheatgrass supporting medical research? |
| Answer |
| Yes, in a number of different areas. Thalassemia Thalassemic patients suffer from an inherited blood disorder that adversely affects the structure of hemoglobin, the molecule responsible for carrying oxygen around the body. There are a number of different types of this disorder and many patients require regular blood transfusions, often every three or four weeks, throughout their lives. In 2005, scientists at the Murdoch Children's Research Institute in Melbourne, Australia discovered that the wheatgrass extract used in Dr Wheatgrass Supershots contains an as yet unidentified biologically active substance that strongly enhances the production of foetal haemoglobin in human clone cells (More information). This could lead to reduction of blood transfusion requirements in thalassaemic patients constituting a significant medical breakthrough. Dr Wheatgrass is proud to have played an important role in this research and for making a financial contribution to the Institute. View thalassemia testimonials and wheatgrass-related research. Leprosy Ulcers Even though they have been treated and "cured" of leprosy by medication, leprosy patients frequently develop skin ulcers, usually on the feet, which can become indolent and don't heal. Some ulcers persist for more than 30 years. To date, no effective medical treatment has been found to heal these ulcers. By chance, in 2008, we discovered that our Skin Recovery Spray almost healed two ulcers in one of these patients. Subsequently, we funded and and supervised a clinical pilot study using the wheatgrass spray in Indore, India. Preliminary results showed more than 60% of leprous ulcers healed in these patients with significant healing in approximately 80 percent - a remarkable result. Details of the study will be available in 2010. Please click here for more information. Skin Toxicity From Radiation in Breast Cancer Patients Deep X-ray therapy for the treatment of breast cancer can be fraught with complications and adverse reactions called "skin toxicity". Essentially, this means that after treatment, the skin becomes inflamed, tends to blister and break down leading to pain, difficulty in management and wound infection. Because of skin toxicity, the patient has to wait much longer between treatments for the skin to recover sufficiently to allow the next treatment. This in turn tends to reduce the patient's chances of recovery. For over 100 years the inability to successfully manage skin toxicity has been a major management issue, and to date, nothing has been found that can significantly reduce it. Many topical substances have been trialled and tested over the years, but to no avail. In this controlled, double-blind study performed at the School of Clinical Sciences, Charles Sturt University in New South Wales, 29 breast cancer patients applied either sorbolene (current best practice) or a commercially produced wheatgrass-based cream (Dr Wheatgrass Antioxidant Skin Recovery Cream) to the irradiated area three times a day from commencement of radiotherapy. The researchers determined that "the wheatgrass extract delays the severity of acute radiation skin toxicity" and, on the basis of their results, recommended "a larger multicentre randomised trial." (Read full article offsite) |
| Categories |
| About our Company, Medical & miscellaneous conditions |
| Back to FAQs |
